Cited by 120Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance

Open access
The RISC Investigators, Mari, A., Tura, A., Natali, A., Laville, M., Laakso, M., Gabriel, R., Beck-Nielsen, H. +1 more·2010·Diabetologia

Abstract

Aims/hypothesis It is commonly thought that hyperglycaemia results from insufficient compensation of insulin secretion for insulin resistance. To verify this hypothesis, we assessed beta cell function and insulin sensitivity (IS) in a large cohort of volunteers with normal glucose tolerance (NGT) or impaired glucose regulation (IGR), i.e. impaired glucose tolerance or impaired fasting glucose. Methods In men and women with NGT (n=1,123) or IGR(n=156) (age 44 +/- 8 years, BMI 25+/-4 kg/m2, mean +/- SD)we measured: (1) IS by clamp; (2) insulin secretion rates(ISR) and beta cell glucose sensitivity (=slope of the insulin secretion/plasma glucose dose-response) by C-peptide deconvolution and OGTT modelling; and (3) acute insulin response to intravenous glucose. Results After controlling for centre, sex, age and BMI, fasting and total ISR were inversely related to IS in both groups,whereas beta cell glucose sensitivity was not. Acute insulin response was reciprocally related to IS in both groups, but the relationships were incompatible with inadequate compensation and significance was lost after controlling for fasting ISR. InIGR vs NGT, IS was impaired (92 [75] vs 133 [86] micromol min(-1)[kg fat-free mass](-1) [nmol/l](-1), median [interquartile range],p<0.0001) as was beta cell glucose sensitivity (69 [46] vs 119[83] pmol min(-1) m(-2) [nmol/l](-1), p<0.0001), whereas fasting and total ISR were increased (35% and 25%, respectively, p<0.0001). In fully adjusted models, beta cell glucose sensitivity was the strongest determinant of OGTT glucose levels. Conclusions/interpretation Insulin resistance normally upregulates the secretory tone, with no evidence of defective compensation in IGR. In contrast, beta cell glucose sensitivity is independent of insulin resistance, but a key determinant of glucose tolerance. This suggests that hyperglycaemia results from an intrinsic beta cell defect rather than from inadequate compensation for insulin resistance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-009-1647-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The slope of the relationship between glucose and insulin secretion (β-CGS) is a major controller of postprandial glucose levels.

    “The slope of the relationship between glucose and insulin secretion (ie, β -CGS) is a major controller of postprandial glu­ cose levels (23, 24).”

    From Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test (2024) · cites this paper as [23]

    The Methods define β-cell glucose sensitivity as the slope of the insulin-secretion response to glucose. The Results and Discussion identify it as the largest contributor to glucose levels during an oral glucose tolerance test, but the paper assesses a glucose load rather than a meal and does not establish that the slope controls postprandial glucose levels generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Kahn SE, Porte D Jr (2003) The pathophysiology and genetics of type 2 diabetes mellitus. In: Porte D Jr, Sherwin R, Baron A (eds) Ellenberg and Rifkin's diabetes mellitus, 6th edn. McGraw-Hill, New York, pp 331-365
  2. DeFronzo RA, Mandarino L, Ferrannini E (2004) Metabolic and molecular pathogenesis of type 2 diabetes mellitus. In: DeFronzo RA, Ferrannini E, Keen H, Zimmet P (eds) International textbook of diabetes mellitus, 3rd edn. Wiley, Chichester

Cited by

Sorted by citations

Authors
The RISC Investigators, Mari, A., Tura, A., Natali, A., Laville, M., Laakso, M., Gabriel, R., Beck-Nielsen, H., & Ferrannini, E.
Affiliations
  • National Research Council (IT)
  • University of Pisa (IT)
  • Lyon 1 Université (FR)
  • University of Eastern Finland (FI)
  • Hospital Universitario La Paz (ES)
Corresponding author
Mari, A.
Venue
Diabetologia
Published
2010-01-09
Volume
53
Issue
4
Pages
749-756
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2028113047
Cited by
120
References
1
Citations by year
2026: 4 · 2025: 7 · 2024: 7 · 2023: 3 · 2022: 10 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 12 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 7 · 2012: 9
FWCI
11.83
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Funders
AstraZeneca (QLG1-CT-2001-01252)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
beta-cell glucose sensitivity, insulin resistance, impaired glucose tolerance, impaired fasting glucose, insulin secretion rate, insulin sensitivity, acute insulin response, hyperglycemia
MeSH terms
Adult, Blood Glucose, C-Peptide, Fasting, Female, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin Resistance, Male, Middle Aged, Glucose Intolerance, Patch-Clamp Techniques, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review